With a big cash as­sist from lo­cal of­fi­cials, BeiGene is build­ing a $330M bi­o­log­ics fa­cil­i­ty in Chi­na

In the lat­est sign that Chi­na’s biotech in­dus­try is de­vel­op­ing at high speed, one of its most promi­nent biotechs is prepar­ing to break dirt on a $330 mil­lion bi­o­log­ics man­u­fac­tur­ing cen­ter in Guangzhou which will al­so pro­vide some di­rect sup­port for R&D ac­tiv­i­ties.

BeiGene struck a deal to build the fa­cil­i­ty in part­ner­ship with lo­cal de­vel­op­ment of­fi­cials who are kick­ing in close to half of the mon­ey. The biotech will part­ner with Guangzhou GET Tech­nol­o­gy De­vel­op­ment Co., which is con­tribut­ing $150 mil­lion in cash and con­vert­ible loans for the joint ven­ture. BeiGene will pro­vide $30 mil­lion of the cost and the rest will be cov­ered by loans.

Unlock this article instantly by becoming a free subscriber.

You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.

SIGN UP LOG IN BECOME A PREMIUM SUBSCRIBER